Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing
Podcast Image

NPR News Now

NPR News: 06-01-2026 12PM EDT

01 Jun 2026

Transcription

Transcript generated automatically by AI and may contain errors.

Chapter 1: What is the main topic discussed in this episode?

1.465 - 4.251 Lakshmi Singh

Live from NPR News, I'm Lakshmi Singh.

0

Chapter 2: What recent developments are happening with Iran's negotiations?

5.333 - 29.905 Lakshmi Singh

A semi-official Iranian news agency says the Islamic Republic is suspending talks via mediators with the United States. Tostin reports Iran's halting indirect communications over expanding Israeli military operations in southern Lebanon and in Gaza. The issue of presidential war powers is one item on a long to-do list Congress faces as it returns from recess.

0

30.446 - 40.348 Lakshmi Singh

NPR's Eric McDaniel reports the Senate had advanced a measure that would force an end to the conflict, in part because President Trump keeps making enemies of Senate Republicans.

0

40.328 - 76.798 Unknown

Right. All of this voting is mostly symbolic, though the president can veto any war powers resolutions constraining the war that get to his desk. But it's worth noting, of course, the Constitution gives Congress the power to declare war and regulate conflict, and the president is legally required to get their approval in order to continue his Iran war.

0

76.778 - 87.693 Lakshmi Singh

Eric McDaniel reporting. Three Ebola vaccine candidates are being fast-tracked for development by the Coalition for Epidemic Preparedness, a global health organization. Here's NPR's Jonathan Lambert.

0

87.713 - 106.617 Jonathan Lambert

The Ebola outbreak centered in the Democratic Republic of Congo is already one of the largest on record with over 1,100 suspected cases. It's driven by a rarer species of Ebola, Bundabujo, for which there are no approved vaccines or treatments. But there are several candidate vaccines, and three will receive millions of dollars to jumpstart development.

107.258 - 122.395 Jonathan Lambert

One is a Bundabujo version of the Ervbo vaccine, which was approved for a different Ebola strain. Another is being developed by the University of Oxford using a platform similar to the Oxford AstraZeneca COVID vaccine. And the third is an mRNA vaccine from Moderna.

122.375 - 131.946 Jonathan Lambert

It takes time for manufacturers to make enough product for clinical trials, so it'll likely be several months before any candidate reaches the outbreak. Jonathan Lambert, NPR News.

132.398 - 140.206 Lakshmi Singh

The Atlantic hurricane season formally begins today. NPR's Julia Simon says forecasters are predicting a below average number of named storms.

140.306 - 159.486 Julia Simon

Last month, forecasters with the National Oceanic and Atmospheric Administration said they expected this year's Atlantic hurricane season to be relatively quiet. NOAA is predicting three to six hurricanes, while seven is the average annual number. That's in large part because the El Nino weather pattern will likely emerge this year.

Comments

There are no comments yet.

Please log in to write the first comment.